Imprint
Information about the publisher of this site — Latin American edition (Spanish).
Publisher
The Nootropic Lab Editorial Team
The Nootropic Lab is an independent editorial publication that reviews cognitive supplements using a transparent five-pillar methodology. We operate as an editorial collective and do not disclose individual contributors by name. Reviews are produced collaboratively by editors with backgrounds in pharmacology, evidence synthesis, and consumer-product analysis.
We do not accept payment for reviews, do not feature sponsored placements, and disclose every commercial relationship via our affiliate-link policy. See our methodology for the full scoring framework.
Contact
Editorial corrections, regulatory inquiries, partnership requests:
We aim to respond to substantive editorial corrections within 5 business days and to update or retract incorrect content within 10 business days of verification.
Editorial standards
- Every product review applies the same five-pillar scoring framework.
- Ingredient doses are evaluated against minimum effective doses from peer-reviewed human clinical trials (PubMed-indexed).
- Affiliate disclosure renders at the top of every commercial page, before the first call-to-action.
- Catalog products (entries based on public product information) and hands-on tested products are visually distinguished by a badge.
- Region-specific regulatory disclaimers are surfaced on every commercial page (DSHEA, EFSA, TGA, NPN, FFC, ANMAT, SFDA, BPJPH/JAKIM, etc.).
- Errors are corrected promptly and transparently. We never delete or quietly edit factual claims after publication.
Regional note
Los suplementos alimenticios están regulados por agencias nacionales: ANVISA (Brasil) bajo RDC 243/2018, COFEPRIS (México), e INVIMA (Colombia). En Argentina, ANMAT Disposición 2105/2022 prohíbe ciertos compuestos nootrópicos (incluyendo Noopept) — no recomendamos productos con esos ingredientes a lectores en Argentina. / Supplements are regulated by national agencies: ANVISA (Brazil), COFEPRIS (Mexico), INVIMA (Colombia). In Argentina, ANMAT Disposition 2105/2022 prohibits certain nootropic compounds (including Noopept) — we do not recommend products containing those ingredients to Argentine readers.
Affiliate relationships
This site contains affiliate links. When a reader clicks through and purchases, we may receive a commission at no additional cost to the reader. Affiliate relationships do not influence editorial scores or ranking position. Read the full disclosure on each commercial page or in our cookie policy.
Last updated: May 27, 2026